Pfizer Jumps On Mixed, But 'Marginally Encouraging,' Guidance - Investor's Business Daily

1. Pfizer Jumps On Mixed, But 'Marginally Encouraging,' Guidance  Investor's Business Daily
2. Pfizer Shares Jump 4% on Positive 2025 Outlook Despite $1B Impact  Yahoo Finance
3. Pfizer Sees 2025 Revenue in Line With Wall Street Views  The Wall Street Journal
4. Pfizer’s In-Line Guidance Offers Relief to Weary Investors  Bloomberg